As of 2026-04-04, the Intrinsic Value of Vincerx Pharma Inc (VINC) is -214.81 USD. This VINC valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.10 USD, the upside of Vincerx Pharma Inc is -214,914.50%.
Based on its market price of 0.10 USD and our intrinsic valuation, Vincerx Pharma Inc (VINC) is overvalued by 214,914.50%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -214.81 - -214.81 | -214.81 | -214,914.50% |
| P/E | (893.63) - (940.89) | (938.74) | -938838.4% |
| DDM - Stable | (254.30) - (690.90) | (472.60) | -472701.4% |
| DDM - Multi | (203.65) - (453.66) | (283.70) | -283795.7% |
| Market Cap (mil) | 0.07 |
| Beta | -3.02 |
| Outstanding shares (mil) | 0.70 |
| Enterprise Value (mil) | -4.92 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.71% |
| Cost of Debt | 5.00% |
| WACC | 8.19% |